Celltrion Pharm Obtains Integrated Certification for International Standards ISO 37001 and 37301

Establishing a Global Standard Compliance and Ethical Management System

Celltrion Pharm announced on September 30 that it has obtained integrated certification for ISO 37001 (Anti-Bribery Management System) and ISO 37301 (Compliance Management System) from the Korea Compliance Promotion Institute (KCI).

Youngho Yoo, CEO of Celltrion Pharm (right), and Jungmyung Lee, President of the Korea Compliance Promotion Institute (left), are holding certificates and posing for a commemorative photo. Celltrion Pharm

ISO 37001, established by the International Organization for Standardization (ISO), is a management system that requires the identification, prevention, and response to risks of bribery and corruption. ISO 37301 is an international certification that evaluates a company's legal compliance, risk prevention, and sustainable management systems. Celltrion Pharm received this integrated certification in recognition of its practical efforts, including enhancing internal regulations, expanding compliance training for employees, and strengthening ongoing monitoring and internal audits.

Through this certification, Celltrion Pharm has demonstrated externally that it has established a compliance and ethical management system in line with international standards, and expects this will further strengthen trust with global partners and clients. Based on this, the company plans to reinforce transparency in decision-making and internal control systems, and continuously incorporate certification requirements throughout its management to elevate its ESG capabilities to the highest global standards.

Additionally, Celltrion Pharm will establish a continuous monitoring system to maintain certification and prepare for follow-up audits, while also expanding proactive management and customized training for employees. The company also plans to reflect fair and ethical issues in regular internal audits to further enhance governance transparency.

A Celltrion Pharm representative stated, "This integrated certification demonstrates that Celltrion Pharm has embedded a compliance and ethical management system, meeting international standards, throughout its operations. We will continue to enhance trust and competitiveness as a global pharmaceutical company through transparent governance and responsible business practices."

Meanwhile, in February, Celltrion Pharm held a declaration ceremony for the introduction of its Fair Trade Compliance Program (CP), officially expressing its commitment to expanding fair trade and ethical business activities. The acquisition of this ISO integrated certification is seen as evidence that these efforts are being established as part of the company's internal systems and culture.

This content was produced with the assistance of AI translation services.